Insperity NSP

NYSE NSP

$50.24 +0.61 (+1.23%)

As of: Sep 9, 2026 · 3:59 PM EDT

Key Stats

Market Cap1.91 Bn

P/E-119.09

P/S0.28

Div. Yield0.05

Total Debt (Qtr)419.00 Mn

Revenue Growth (1y) (Qtr)1.69

Add ratio to table…

About

Insperity, Inc. is a professional employer organization that provides outsourced human resources solutions to small and medium sized businesses in the United States. The company acts as a coemployer managing payroll, benefits administration, risk management, and regulatory compliance for its clients. By pooling employees across many client firms Insperity achieves economies of scale that enable it to offer a broad range of HR services and benefits typically available only to larger enterprises. Insperity employed approximately 4,200 corporate employees as of December 31, 2025 and maintained 90 sales offices in 44 markets to support its service delivery. The firm’s retention rate for PEO HR Solutions clients was approximately 83% in 2025 reflecting stable long term relationships.

Insperity generates revenue primarily through service fees charged under its PEO HR Solutions agreements which are based on each client’s payroll and the breadth of services selected. In addition to its core PEO offering the company sells stand alone products including a comprehensive traditional payroll and human capital management solution (HR Core), talent acquisition services, retirement plan administration, insurance services, contractor management, and the Perks+ earned wage access program. These supplementary offerings are sold either separately or bundled with the PEO HR Solutions to increase wallet share and client retention. The company’s service fees are subject to periodic adjustments to reflect changes in workforce composition, benefit elections, and statutory cost fluctuations. Revenue from stand alone offerings contributes a growing portion of total sales as Insperity leverages its existing client relationships for cross selling.

Insperity is regarded as 1 of the largest professional employer organizations in the United States competing with national players such as the PEO divisions of Automatic Data Processing Inc and Paychex Inc, as well as standalone PEOs like TriNet Group Inc, Vensure, and Rippling. The company differentiates itself through a full service approach that combines a high staff to worksite employee ratio, proprietary technology platforms such as Insperity Premier and Workday HCM based tenants, and a broad suite of employee benefits negotiated with carriers like UnitedHealthcare and Chubb. These capabilities allow Insperity to deliver superior service quality and regulatory expertise which support premium pricing and strong gross profit per worksite employee relative to industry averages. Insperity’s focus on regulatory compliance and its status as a certified professional employer organization under the Small Business Efficiency Act further strengthen its market position and reduce client concerns about coemployer arrangements. The firm invests continuously in AI based tools to enhance service delivery and maintain a competitive edge in technology driven HR solutions.

Insperity serves a diverse base of small and medium sized businesses ranging from firms with approximately 10 employees to those with up to 5,000 worksite employees. The client base spans numerous industries including manufacturing, health care, retail, professional services, and technology reflecting the company’s strategy to avoid concentration in any single sector. While the filing does not disclose specific customer names the company notes that its clients are located throughout the United States with notable concentrations in Texas, California, and New York which accounted for roughly 17%, 15%, and 10% of worksite employees respectively in 2025. The firm reported an average annual retention rate of approximately 84% over the last five years indicating steady client loyalty. Insperity’s PEO HR Solutions are designed to attract and retain high quality employees while relieving client owners and key executives of many employer related administrative and regulatory burdens.

Investment Thesis

▲ Bull case

Insperity is positioned to benefit from a structural shift in the small and medium-sized business (SMB) market driven by AI adoption, where its HRScale platform serves as a critical enabler for businesses seeking to manage workforce disruption without the complexity and cost of traditional HCM systems. Management emphasized that HRScale addresses a historical "success penalty" where matured clients leave for technology built for larger firms, and its early traction—with nearly 6,000 worksite employees committed for onboarding within six months and a strong pipeline of upgrades and new accounts—suggests it could become a durable growth catalyst starting in 2027. This is particularly significant as SMB leaders view HRScale as a lower-risk decision due to reduced upfront investment, faster time-to-value, and lower ongoing costs compared to multi-vendor alternatives, which could drive sustained demand even amid macroeconomic uncertainty. The company’s positioning as a premium HR channel partner for AI adoption among SMBs—leveraging its trusted relationships to deliver secure, practical AI solutions—further amplifies this opportunity, as AI-driven transformations increase the need for sophisticated HR expertise that Insperity uniquely provides.
Despite near-term headwinds in worksite employee growth, Insperity’s margin recovery plan is demonstrating tangible progress and may be ahead of schedule, creating a powerful offset to volume declines. The Q1 2026 results showed gross profit per worksite employee of $332 per month—slightly above forecast and within expectations—driven by lower-than-expected benefit costs, which benefited from favorable client mix changes due to pricing and retention strategies, plan design changes, and the new UnitedHealthcare contract. Benefit cost per covered employee rose only 5% year-over-year, a meaningful improvement from the 9% average seen throughout 2025, signaling that the company’s efforts to flatten claims volatility are taking hold. Crucially, management noted that the UnitedHealthcare contract’s impact is back-end loaded, meaning its full benefit to earnings will accrue in later quarters, implying that margin improvement could accelerate through the year even if early results appear modest. This dynamic supports the company’s decision to reiterate its full-year adjusted EBITDA guidance of $170–$230 million despite lowering worksite employee expectations, reflecting confidence that profitability per employee will rise sufficiently to offset volume pressure.
Insperity’s capital allocation and operational discipline are creating a foundation for sustainable returns, with early signs that HRScale investment costs will begin to decline as the platform scales. Management confirmed that investment in HRScale is expected to taper in the second half of 2026 as personnel involved in development transition to service and onboarding roles tied to revenue generation, reducing the drag on operating expenses. This shift—where costs that were previously expensed are now being offset by deployment fees and recurring revenue—could meaningfully improve operating leverage as HRScale ramps. Combined with ongoing headcount reductions and lower HRScale expenses (partially offset by modest marketing spend and Business Performance Advisor growth), the company expects continued year-over-year operating expense reductions in 2026. This cost discipline, coupled with a flattening quarterly earnings pattern from the UnitedHealthcare contract changes, positions Insperity to deliver more predictable and potentially stronger second-half performance, which may be underappreciated by the market focused on near-term worksite employee declines.

Insperity is positioned to benefit from a structural shift in the small and medium-sized business (SMB) market driven by AI adoption, where its HRScale platform serves as a critical enabler for businesses seeking to manage workforce disruption without the complexity and cost of traditional HCM systems. Management emphasized that HRScale addresses a historical "success penalty" where matured clients leave for technology built for larger firms, and its early traction—with nearly 6,000 worksite employees committed for onboarding within six months and a strong pipeline of upgrades and new accounts—suggests it could become a durable growth catalyst starting in 2027. This is particularly significant as SMB leaders view HRScale as a lower-risk decision due to reduced upfront investment, faster time-to-value, and lower ongoing costs compared to multi-vendor alternatives, which could drive sustained demand even amid macroeconomic uncertainty. The company’s positioning as a premium HR channel partner for AI adoption among SMBs—leveraging its trusted relationships to deliver secure, practical AI solutions—further amplifies this opportunity, as AI-driven transformations increase the need for sophisticated HR expertise that Insperity uniquely provides.
Despite near-term headwinds in worksite employee growth, Insperity’s margin recovery plan is demonstrating tangible progress and may be ahead of schedule, creating a powerful offset to volume declines. The Q1 2026 results showed gross profit per worksite employee of $332 per month—slightly above forecast and within expectations—driven by lower-than-expected benefit costs, which benefited from favorable client mix changes due to pricing and retention strategies, plan design changes, and the new UnitedHealthcare contract. Benefit cost per covered employee rose only 5% year-over-year, a meaningful improvement from the 9% average seen throughout 2025, signaling that the company’s efforts to flatten claims volatility are taking hold. Crucially, management noted that the UnitedHealthcare contract’s impact is back-end loaded, meaning its full benefit to earnings will accrue in later quarters, implying that margin improvement could accelerate through the year even if early results appear modest. This dynamic supports the company’s decision to reiterate its full-year adjusted EBITDA guidance of $170–$230 million despite lowering worksite employee expectations, reflecting confidence that profitability per employee will rise sufficiently to offset volume pressure.
Insperity’s capital allocation and operational discipline are creating a foundation for sustainable returns, with early signs that HRScale investment costs will begin to decline as the platform scales. Management confirmed that investment in HRScale is expected to taper in the second half of 2026 as personnel involved in development transition to service and onboarding roles tied to revenue generation, reducing the drag on operating expenses. This shift—where costs that were previously expensed are now being offset by deployment fees and recurring revenue—could meaningfully improve operating leverage as HRScale ramps. Combined with ongoing headcount reductions and lower HRScale expenses (partially offset by modest marketing spend and Business Performance Advisor growth), the company expects continued year-over-year operating expense reductions in 2026. This cost discipline, coupled with a flattening quarterly earnings pattern from the UnitedHealthcare contract changes, positions Insperity to deliver more predictable and potentially stronger second-half performance, which may be underappreciated by the market focused on near-term worksite employee declines.

▼ Bear case

Insperity’s worksite employee growth is facing persistent structural headwinds from deteriorating SMB sentiment and macroeconomic uncertainty, which management acknowledged are suppressing hiring and expansion among its client base, with no clear near-term reversal in sight. The average number of paid worksite employees declined 1.0% year-over-year in Q1 2026 to 303,049—at the low end of the forecasted range—and client attrition remained at the higher end of historical levels at 11%. Management cited weakening small business economic sentiment, inflation fears, and lingering tariff uncertainty as key factors reducing confidence in hiring, compensation increases, and capital spending, with its internal survey showing 54% of clients now expecting a negative business impact in 2026 (up from 42% in January) and only 25% foreseeing positive effects. This sentiment shift is corroborated by declining overtime and commission trends, which historically precede hiring and pay raises, suggesting that the drag on worksite employee growth is not merely seasonal but rooted in a broader pullback in SMB activity that could persist through 2026 and beyond, undermining a core driver of revenue.
The company’s margin recovery progress, while showing early signs of improvement, remains fragile and potentially overstated, with benefits highly dependent on transient factors that may not sustain through the year. Although Q1 benefit costs rose only 5% year-over-year—down from the 9% average in 2025—management attributed much of this to favorable runoff of prior period claims, reduced large claim activity, and lower-than-expected pharmacy claims, which are inherently variable and not guaranteed to continue. The improvement in gross profit per worksite employee to $322 per month was also partly driven by lower worksite employee volume, which reduces the denominator and flattered the metric. Furthermore, management explicitly stated that the favorability seen in Q1 is expected to be “somewhat less” in the remainder of the year, indicating that the current pace of margin recovery may not be maintainable. The UnitedHealthcare contract’s back-end loaded benefit, while noted as a future tailwind, also means that early-year earnings pressure could persist, and any disappointment in claims trends would directly undermine the margin recovery thesis, leaving the company vulnerable if volume declines continue without commensurate pricing or mix benefits.
Insperity’s reliance on HRScale as a future growth engine carries significant execution risk, with the platform currently in a costly ramp-up phase that may not translate into meaningful revenue or earnings contributions for an extended period, and competitive pressures could erode its differentiated positioning. Although nearly 6,000 worksite employees are committed for onboarding within six months, these represent upgrades from existing HR360 clients rather than net new worksite employee additions, meaning they do not immediately expand the revenue base and primarily serve to improve retention. True growth from new HRScale accounts is expected to materialize only with January 1, April 1, or July 1, 2027 start dates, implying a substantial delay before the platform meaningfully impacts top-line growth. Meanwhile, ongoing investment—$13 million in Q1 2026 alone, split between operating expenses and capitalized costs—continues to weigh on profitability, and while management expects investment costs to decline in the second half of 2026, the transition from development to service roles depends on successful sales execution. If client adoption slows due to macroeconomic caution or if competitors accelerate their own integrated HCM offerings for the mid-market, Insperity could face prolonged drag on margins without the promised growth payoff, especially given its already modest worksite employee growth outlook of -1% to -2.3% for the full year 2026.

Insperity’s worksite employee growth is facing persistent structural headwinds from deteriorating SMB sentiment and macroeconomic uncertainty, which management acknowledged are suppressing hiring and expansion among its client base, with no clear near-term reversal in sight. The average number of paid worksite employees declined 1.0% year-over-year in Q1 2026 to 303,049—at the low end of the forecasted range—and client attrition remained at the higher end of historical levels at 11%. Management cited weakening small business economic sentiment, inflation fears, and lingering tariff uncertainty as key factors reducing confidence in hiring, compensation increases, and capital spending, with its internal survey showing 54% of clients now expecting a negative business impact in 2026 (up from 42% in January) and only 25% foreseeing positive effects. This sentiment shift is corroborated by declining overtime and commission trends, which historically precede hiring and pay raises, suggesting that the drag on worksite employee growth is not merely seasonal but rooted in a broader pullback in SMB activity that could persist through 2026 and beyond, undermining a core driver of revenue.
The company’s margin recovery progress, while showing early signs of improvement, remains fragile and potentially overstated, with benefits highly dependent on transient factors that may not sustain through the year. Although Q1 benefit costs rose only 5% year-over-year—down from the 9% average in 2025—management attributed much of this to favorable runoff of prior period claims, reduced large claim activity, and lower-than-expected pharmacy claims, which are inherently variable and not guaranteed to continue. The improvement in gross profit per worksite employee to $322 per month was also partly driven by lower worksite employee volume, which reduces the denominator and flattered the metric. Furthermore, management explicitly stated that the favorability seen in Q1 is expected to be “somewhat less” in the remainder of the year, indicating that the current pace of margin recovery may not be maintainable. The UnitedHealthcare contract’s back-end loaded benefit, while noted as a future tailwind, also means that early-year earnings pressure could persist, and any disappointment in claims trends would directly undermine the margin recovery thesis, leaving the company vulnerable if volume declines continue without commensurate pricing or mix benefits.
Insperity’s reliance on HRScale as a future growth engine carries significant execution risk, with the platform currently in a costly ramp-up phase that may not translate into meaningful revenue or earnings contributions for an extended period, and competitive pressures could erode its differentiated positioning. Although nearly 6,000 worksite employees are committed for onboarding within six months, these represent upgrades from existing HR360 clients rather than net new worksite employee additions, meaning they do not immediately expand the revenue base and primarily serve to improve retention. True growth from new HRScale accounts is expected to materialize only with January 1, April 1, or July 1, 2027 start dates, implying a substantial delay before the platform meaningfully impacts top-line growth. Meanwhile, ongoing investment—$13 million in Q1 2026 alone, split between operating expenses and capitalized costs—continues to weigh on profitability, and while management expects investment costs to decline in the second half of 2026, the transition from development to service roles depends on successful sales execution. If client adoption slows due to macroeconomic caution or if competitors accelerate their own integrated HCM offerings for the mid-market, Insperity could face prolonged drag on margins without the promised growth payoff, especially given its already modest worksite employee growth outlook of -1% to -2.3% for the full year 2026.

Geographical Breakdown of Revenue (2025)

Peer group

Peer Comparison

Companies in the Staffing

S.No.	Ticker	Company	match	Market Cap	P/E	P/S	Total Debt (Qtr)
1	TNET	Trinet Group, Inc.	primary	3.06 Bn	17.49	0.63	0.90 Bn
2	MAN	ManpowerGroup Inc.	primary	2.67 Bn	39.06	0.14	1.04 Bn
3	NSP	Insperity, Inc.	primary	1.91 Bn	-119.09	0.28	0.42 Bn
4	AMN	Amn Healthcare Services Inc	primary	1.34 Bn	12.81	0.39	0.01 Bn
5	BBSI	Barrett Business Services Inc	primary	0.79 Bn	22.53	0.62	-
6	QH	QUHUO Ltd	primary	0.56 Bn	-69.96	0.59	0.02 Bn
7	KELYA	Kelly Services Inc	primary	0.55 Bn	-2.02	0.14	0.08 Bn
8	CCRN	Cross Country Healthcare Inc	primary	0.43 Bn	-4.23	0.43	-

Insperity NSP

About

Investment Thesis

Geographical Breakdown of Revenue (2025)

Peer Comparison

Create an account

Sign In

Reset Password